Roche to acquire SAGA Diagnostics in $595m deal
The world’s largest biotechnology company Roche Holding has signed a definitive agreement to acquire the Swedish precision medicine company SAGA Diagnostics for up to $595m. The transaction, which includes upfront considerations alongside commercial and regulatory milestone payments, is expected to close in Q3 2026 subject to customary regulatory approvals. Upon completion, SAGA Diagnostics will be fully integrated into Foundation Medicine,…